PVI
Pura Vida Investments Portfolio holdings
AUM
$16.6M
This Quarter Return
+5.37%
1 Year Return
-3.82%
3 Year Return
-0.02%
5 Year Return
+29.84%
10 Year Return
+256.58%
AUM
$596M
AUM Growth
-$67.1M
(-10%)
Cap. Flow
-$103M
Cap. Flow
% of AUM
-17.22%
Top 10 Holdings %
Top 10 Hldgs %
55.37%
Holding
215
New
32
Increased
15
Reduced
34
Closed
44
Top Buys
| 1 |
Biogen
BIIB
|
$16M |
| 2 |
SONX
Sonendo, Inc.
SONX
|
$11M |
| 3 |
Azenta
AZTA
|
$7.34M |
| 4 |
Quanterix
QTRX
|
$7.09M |
| 5 |
Natera
NTRA
|
$6.63M |
Top Sells
| 1 |
United Therapeutics
UTHR
|
$24.7M |
| 2 |
Cytokinetics
CYTK
|
$12.6M |
| 3 |
Outset Medical
OM
|
$11.6M |
| 4 |
Illumina
ILMN
|
$10.5M |
| 5 |
AstraZeneca
AZN
|
$9.6M |
Sector Composition
| 1 | Healthcare | 88.87% |
| 2 | Industrials | 0.83% |
| 3 | Consumer Staples | 0% |
| 4 | Financials | 0% |
| 5 | Materials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Terns Pharmaceuticals
TERN
$651M
| $6.16M | 0.32% |
605,079
-123,521
| -17% | -$1.26M |
|
27
TELA Bio
TELA
$65.4M
| $5.98M | 0.31% |
520,079
| – | – |
|
28
TG Therapeutics
TGTX
$5.03B
| $5.97M | 0.31% |
504,829
-695,984
| -58% | -$8.23M |
|
29
Lantheus
LNTH
$3.75B
| $5.95M | 0.31% |
116,665
-7,100
| -6% | -$362K |
|
|
IMDX
30
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$73.3M
| $5.79M | 0.3% |
902,814
| – | – |
|
31
Bio-Techne
TECH
$8.3B
| $5.64M | 0.29% |
+68,000
| New | +$5.64M |
|
32
Transmedics
TMDX
$3.65B
| $5.55M | 0.29% |
90,000
-30,000
| -25% | -$1.85M |
|
33
Cooper Companies
COO
$13.3B
| $5.09M | 0.26% |
61,600
-9,392
| -13% | -$776K |
|
34
KalVista Pharmaceuticals
KALV
$713M
| $4.95M | 0.26% |
732,702
-100,000
| -12% | -$676K |
|
|
RCM
35
DELISTED
R1 RCM Inc. Common Stock
RCM
| $4.93M | 0.25% |
450,000
+189,600
| +73% | +$2.08M |
|
36
Schrodinger
SDGR
$1.42B
| $4.86M | 0.25% |
260,000
| – | – |
|
37
Cytek Biosciences
CTKB
$501M
| $4.3M | 0.22% |
420,749
-106,415
| -20% | -$1.09M |
|
38
BioNTech
BNTX
$24.1B
| $4.24M | 0.22% |
+28,195
| New | +$4.24M |
|
39
Prothena Corp
PRTA
$452M
| $3.86M | 0.2% |
+64,000
| New | +$3.86M |
|
40
NovoCure
NVCR
$1.35B
| $3.67M | 0.19% |
+50,000
| New | +$3.67M |
|
41
Evolent Health
EVH
$1.11B
| $3.26M | 0.17% |
+116,200
| New | +$3.26M |
|
42
Vaxcyte
PCVX
$4.17B
| $2.95M | 0.15% |
+61,528
| New | +$2.95M |
|
43
Steris
STE
$23.9B
| $2.86M | 0.15% |
+15,500
| New | +$2.86M |
|
44
Intuitive Surgical
ISRG
$158B
| $2.65M | 0.14% |
10,000
-9,732
| -49% | -$2.58M |
|
45
Incyte
INCY
$17B
| $2.44M | 0.13% |
+30,400
| New | +$2.44M |
|
|
KDNY
46
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $2.36M | 0.12% |
+90,000
| New | +$2.36M |
|
|
TSVT
47
DELISTED
2seventy bio
TSVT
| $2.35M | 0.12% |
251,309
-73,691
| -23% | -$690K |
|
|
RXDX
48
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $2.31M | 0.12% |
21,000
-8,188
| -28% | -$901K |
|
|
INBX
49
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $2.31M | 0.12% |
+93,575
| New | +$2.31M |
|
50
Nuvalent
NUVL
$5.74B
| $2.1M | 0.11% |
+70,523
| New | +$2.1M |
|